These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 24987096
1. IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM. Chung LK, Philip NH, Schmidt VA, Koller A, Strowig T, Flavell RA, Brodsky IE, Bliska JB. mBio; 2014 Jul 01; 5(4):e01402-14. PubMed ID: 24987096 [Abstract] [Full Text] [Related]
2. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. Zheng Y, Lilo S, Brodsky IE, Zhang Y, Medzhitov R, Marcu KB, Bliska JB. PLoS Pathog; 2011 Apr 01; 7(4):e1002026. PubMed ID: 21533069 [Abstract] [Full Text] [Related]
3. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense. Zheng Y, Lilo S, Mena P, Bliska JB. PLoS One; 2012 Apr 01; 7(4):e36019. PubMed ID: 22563435 [Abstract] [Full Text] [Related]
4. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence. Schoberle TJ, Chung LK, McPhee JB, Bogin B, Bliska JB. Infect Immun; 2016 Apr 01; 84(4):1062-1072. PubMed ID: 26810037 [Abstract] [Full Text] [Related]
5. Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ. Lilo S, Zheng Y, Bliska JB. Infect Immun; 2008 Sep 01; 76(9):3911-23. PubMed ID: 18559430 [Abstract] [Full Text] [Related]
6. Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eucaryotic cells. Skrzypek E, Myers-Morales T, Whiteheart SW, Straley SC. Infect Immun; 2003 Feb 01; 71(2):937-47. PubMed ID: 12540576 [Abstract] [Full Text] [Related]
12. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. Infect Immun; 2004 Aug 14; 72(8):4589-602. PubMed ID: 15271919 [Abstract] [Full Text] [Related]
13. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM. McPhee JB, Mena P, Zhang Y, Bliska JB. Infect Immun; 2012 Jul 14; 80(7):2519-27. PubMed ID: 22547545 [Abstract] [Full Text] [Related]
14. Caspase-3 mediates the pathogenic effect of Yersinia pestis YopM in liver of C57BL/6 mice and contributes to YopM's function in spleen. Ye Z, Gorman AA, Uittenbogaard AM, Myers-Morales T, Kaplan AM, Cohen DA, Straley SC. PLoS One; 2014 Jul 14; 9(11):e110956. PubMed ID: 25372388 [Abstract] [Full Text] [Related]
15. The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence. McCoy MW, Marré ML, Lesser CF, Mecsas J. Infect Immun; 2010 Jun 14; 78(6):2584-98. PubMed ID: 20368345 [Abstract] [Full Text] [Related]
19. YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Leung KY, Reisner BS, Straley SC. Infect Immun; 1990 Oct 13; 58(10):3262-71. PubMed ID: 2401564 [Abstract] [Full Text] [Related]
20. Structure-function analysis of Yersinia pestis YopM's interaction with alpha-thrombin to rule on its significance in systemic plague and to model YopM's mechanism of binding host proteins. Hines J, Skrzypek E, Kajava AV, Straley SC. Microb Pathog; 2001 Apr 13; 30(4):193-209. PubMed ID: 11312613 [Abstract] [Full Text] [Related] Page: [Next] [New Search]